Glutamate dehydrogenase (NADP)
Glutamate dehydrogenase (NADP) is the catalytic enzyme for glutamate production. Dysfunction of Glutamate dehydrogenase (NADP) may induce various neurodegenerative diseases, such as Parkinson's disease, epilepsy, Alzheimer's disease, schizophrenia, and frontotemporal dementia. Glutamate dehydrogenase (NADP) can be used in research on neurological diseases such as Parkinson's disease, epilepsy, and Alzheimer's disease[1].
Product Specifications
CAS Number
9029-11-2
UNSPSC
12352204
Target
Biochemical Assay Reagents; Glutamate Dehydrogenase (GLDH)
Type
Enzyme
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/glutamate-dehydrogenase-nadp.html
Solubility
10 mM in DMSO
Smiles
[Glutamatedehydrogenase(NADP)]
References & Citations
[1]Pan C, et al. Glutamate dehydrogenase: Potential therapeutic targets for neurodegenerative disease. Eur J Pharmacol. 2023 Jul 5;950:175733.
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20°C for 2 years
Scientific Category
Enzyme
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF405S conjugate, 0.1mg/mL
CD45 / LCA (136-4B5), CF740 conjugate, 0.1mg/mL
Human Kappa Light Chain (Kap-56), CF740 conjugate, 0.1mg/mL
